Business & Academia Join Forces To Study Magic Mushroom Therapy For IBS Patients
Silo Wellness To Acquire Canadian Dyscovry Science, Producer Of Psilocybin For IBS Treatment
Biomerica Posts Encouraging Results From InFoods Study As Irritable Bowel Syndrome Treatment
Citi, Ladenburg React Positively On Ardelyx's IBS-C Treatment Launch Plans
Irritable Bowel Syndrome Recent News
4D Pharma's Stock Shoots Higher on Positive Data from Irritable Bowel Syndrome Candidate
Arena Pharma's Olorinab Fails To Top Placebo In IBS-Related Abdominal Pain
Hoth Therapeutics Plans To Test HT-003 API In Inflammatory Bowel Disorders; Shares Spike
Synthetic Biologics Surges 25% Amid Positive Phase 2 Data